| A multisociety Delphi consensus statement on new fatty liver disease nomenclature ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, ... Hepatology 78 (6), 1966-1986, 2023 | 1562 | 2023 |
| Advancing the global public health agenda for NAFLD: a consensus statement JV Lazarus, HE Mark, QM Anstee, JP Arab, RL Batterham, L Castera, ... Nature Reviews Gastroenterology & Hepatology 19 (1), 60-78, 2022 | 462 | 2022 |
| Non-alcoholic fatty liver disease: A patient guideline SM Francque, G Marchesini, A Kautz, M Walmsley, R Dorner, JV Lazarus, ... JHEP reports 3 (5), 100322, 2021 | 196 | 2021 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 179 | 2022 |
| Redefining fatty liver disease: an international patient perspective G Shiha, M Korenjak, W Eskridge, T Casanovas, P Velez-Moller, ... The lancet Gastroenterology & hepatology 6 (1), 73-79, 2021 | 176 | 2021 |
| The use of rifaximin in patients with cirrhosis P Caraceni, V Vargas, E Solà, C Alessandria, K de Wit, J Trebicka, ... Hepatology 74 (3), 1660-1673, 2021 | 96 | 2021 |
| Nursing care of patients with cirrhosis: the LiverHope nursing project N Fabrellas, M Carol, E Palacio, M Aban, T Lanzillotti, G Nicolao, ... Hepatology 71 (3), 1106-1116, 2020 | 49 | 2020 |
| A global research priority agenda to advance public health responses to fatty liver disease JV Lazarus, HE Mark, AM Allen, JP Arab, P Carrieri, M Noureddin, ... Journal of hepatology 79 (3), 618-634, 2023 | 40 | 2023 |
| Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study M Serra-Burriel, A Juanola, F Serra-Burriel, M Thiele, I Graupera, E Pose, ... The Lancet 402 (10406), 988-996, 2023 | 35 | 2023 |
| Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment … MG Ghany, M Buti, P Lampertico, HM Lee Hepatology 78 (5), 1654-1673, 2023 | 32 | 2023 |
| Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of life M Carol, M Pérez-Guasch, E Solà, M Cervera, S Martínez, A Juanola, ... PloS one 17 (4), e0265153, 2022 | 27 | 2022 |
| Endpoints and design of clinical trials in patients with decompensated cirrhosis: position paper of the LiverHope Consortium E Solà, E Pose, D Campion, S Piano, O Roux, M Simon-Talero, F Uschner, ... Journal of hepatology 74 (1), 200-219, 2021 | 21 | 2021 |
| What to do about hepatocellular carcinoma: Recommendations for health authorities from the International Liver Cancer Association M Allaire, J Bruix, M Korenjak, S Manes, Z Maravic, H Reeves, R Salem, ... JHEP Reports 4 (12), 100578, 2022 | 20 | 2022 |
| LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries I Graupera, M Thiele, AT Ma, M Serra-Burriel, J Pich, N Fabrellas, ... BMC public health 22 (1), 1385, 2022 | 15 | 2022 |
| MAFLD 2022: An ELPA/ALPA/EASO-ECPO joint statement on disease stigma G Shiha, M Korenjak, T Casanovas, V Mooney, S Sigurðardóttir, Y Koulla, ... Journal of Hepatology 77 (6), 1717-1719, 2022 | 13 | 2022 |
| Treatment with simvastatin and rifaximin restores the plasma metabolomic profile in patients with decompensated cirrhosis E Pose, E Solà, JJ Lozano, A Juanola, J Sidorova, G Zaccherini, K de Wit, ... Hepatology communications 6 (5), 1100-1112, 2022 | 12 | 2022 |
| Uniting to defeat steatotic liver disease: A global mission to promote healthy livers and healthy lives A Krag, M Buti, JV Lazarus, AM Allen, J Bowman, P Burra, G Donnini, ... J. Hepatol 79, 1076-1078, 2023 | 8 | 2023 |
| Communication science in network marketing (NM) D Korenjak, M Plenković, M Korenjak Alma mater Europaea-European Centre, 2013 | 7 | 2013 |
| Screening for fibrosis to diagnose liver diseases early: the LIVERSCREEN project P Ginès, M Thiele, I Graupera, M Serra-Burriel, RJ de Knegt, F Lammert, ... Nature Medicine 29 (4), 774-775, 2023 | 6 | 2023 |
| Monitoring progress towards elimination of hepatitis B and C in the EU/EEA KC Sharrock, T Noori, M Axelsson, M Buti, A Diaz, O Fursa, G Hendrickx, ... PLOS Global Public Health 2 (8), e0000841, 2022 | 5 | 2022 |
